• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二元和三元有序粉末混合物中的颗粒间作用力

Interparticle forces in binary and ternary ordered powder mixes.

作者信息

Staniforth J N, Rees J E, Lai F K, Hersey J A

出版信息

J Pharm Pharmacol. 1982 Mar;34(3):141-5. doi: 10.1111/j.2042-7158.1982.tb04210.x.

DOI:10.1111/j.2042-7158.1982.tb04210.x
PMID:6121889
Abstract

An ultracentrifuge technique, previously described by Staniforth et al (1981), has been used to study the adhesion profiles of several binary and ternary ordered powder mixes of pharmaceutical interest. The adhesion profile of an ordered mix provides information about the proportion of drug powder adhering with different forces of attraction to the carrier excipient particle surface. The excipient particle size is shown to affect adhesion between the components of a binary ordered mix-recrystallized lactose formed more stable ordered mixes with drug powder when the carrier particle size was increased. Changes in the adhesion profile of each binary system on adding three different fine-powder excipients to form a ternary ordered mix are also examined. The physical properties of carrier particles and the charge interactions of a third powder component with previously formed binary ordered mixes, are found to influence the physical stability of ternary ordered mixes.

摘要

一种先前由斯塔尼福思等人(1981年)描述的超速离心技术,已被用于研究几种具有药学意义的二元和三元有序粉末混合物的粘附特性。有序混合物的粘附特性提供了有关药物粉末以不同吸引力附着于载体辅料颗粒表面的比例的信息。结果表明,辅料颗粒大小会影响二元有序混合物各组分之间的粘附力——当载体颗粒尺寸增加时,重结晶乳糖与药物粉末形成更稳定的有序混合物。还研究了在每种二元体系中添加三种不同的细粉辅料以形成三元有序混合物时粘附特性的变化。发现载体颗粒的物理性质以及第三种粉末组分与先前形成的二元有序混合物之间的电荷相互作用会影响三元有序混合物的物理稳定性。

相似文献

1
Interparticle forces in binary and ternary ordered powder mixes.二元和三元有序粉末混合物中的颗粒间作用力
J Pharm Pharmacol. 1982 Mar;34(3):141-5. doi: 10.1111/j.2042-7158.1982.tb04210.x.
2
Fluidized bed film coating of an ordered powder mixture to produce microencapsulated order units.对流化有序粉末混合物进行包衣以生产微囊化有序单元。
J Pharm Pharmacol. 1984 Mar;36(3):145-52. doi: 10.1111/j.2042-7158.1984.tb06928.x.
3
Segregation of vibrated powder mixes containing different concentrations of fine potassium chloride and tablet excipients.含有不同浓度细氯化钾和片剂辅料的振动粉末混合物的分离。
J Pharm Pharmacol. 1983 Sep;35(9):549-54. doi: 10.1111/j.2042-7158.1983.tb04331.x.
4
Determination of interparticulate forces in ordered powder mixes.
J Pharm Pharmacol. 1981 Aug;33(8):485-90. doi: 10.1111/j.2042-7158.1981.tb13845.x.
5
Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles.
Drug Dev Ind Pharm. 1999 Jan;25(1):99-103. doi: 10.1081/ddc-100102148.
6
Relationship between particle packing and the physical stability of powder mixes.颗粒堆积与粉末混合物物理稳定性之间的关系。
J Pharm Pharmacol. 1985 Oct;37(10):692-7. doi: 10.1111/j.2042-7158.1985.tb04944.x.
7
Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.载体微观结构在基于粘合剂/载体的干粉吸入混合物中的作用洞察:载体孔隙率和细颗粒含量。
Eur J Pharm Biopharm. 2015 Oct;96:291-303. doi: 10.1016/j.ejpb.2015.08.006. Epub 2015 Aug 11.
8
A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.精细辅料在载药干粉吸入剂混合物中的新作用:混合过程中药物颗粒解团聚作用的揭示。
AAPS PharmSciTech. 2017 Nov;18(8):2862-2870. doi: 10.1208/s12249-017-0767-4. Epub 2017 Apr 18.
9
The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations.优良辅料颗粒对载体型干粉吸入制剂性能的影响。
Pharm Res. 2006 Aug;23(8):1665-74. doi: 10.1007/s11095-006-9012-7.
10
Electrostatic charge interactions in ordered powder mixes.有序粉末混合物中的静电荷相互作用。
J Pharm Pharmacol. 1982 Feb;34(2):69-76. doi: 10.1111/j.2042-7158.1982.tb04188.x.

引用本文的文献

1
Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles.干粉吸入器中使用的不同载体:其颗粒特性
J Aerosol Med Pulm Drug Deliv. 2024 Dec;37(6):307-327. doi: 10.1089/jamp.2023.0029. Epub 2024 Aug 9.
2
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.干粉吸入器设计和颗粒技术在增强肺部药物沉积中的作用:挑战与未来策略。
Daru. 2024 Dec;32(2):761-779. doi: 10.1007/s40199-024-00520-3. Epub 2024 Jun 11.
3
Development of a formulation of potassium iodide tablets as an antidote against nuclear incidents.
开发碘化钾片剂配方作为应对核事故的解毒剂。
Saudi Pharm J. 2023 Nov;31(11):101814. doi: 10.1016/j.jsps.2023.101814. Epub 2023 Oct 5.
4
Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.冷冻干燥甘露醇干粉吸入剂用于改善肺部药物传递。
Pharm Res. 2013 Feb;30(2):458-77. doi: 10.1007/s11095-012-0892-4. Epub 2012 Oct 16.
5
In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseases.支持用于肺部疾病的干粉吸入器中局部作用药物生物等效性的体外考量因素。
AAPS J. 2009 Sep;11(3):414-23. doi: 10.1208/s12248-009-9121-4. Epub 2009 Jun 3.
6
The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics.干粉吸入剂配方中的内聚-粘附平衡II:对细颗粒递送特性的影响。
Pharm Res. 2004 Oct;21(10):1826-33. doi: 10.1023/b:pham.0000045236.60029.cb.
7
Effect of magnesium stearate on the content uniformity of active ingredient in pharmaceutical powder mixtures.硬脂酸镁对药用粉末混合物中活性成分含量均匀度的影响。
AAPS PharmSciTech. 2002;3(3):E19. doi: 10.1208/pt030319.
8
Particle interactions involved in aerosol dispersion of ternary interactive mixtures.三元相互作用混合物气溶胶分散过程中的颗粒相互作用。
Pharm Res. 2002 Oct;19(10):1524-31. doi: 10.1023/a:1020464801786.
9
Adhesion of powders for inhalation: an evaluation of drug detachment from surfaces following deposition from aerosol streams.
Pharm Res. 2002 Mar;19(3):322-9. doi: 10.1023/a:1014451203619.
10
Can the organization of a binary mix be predicted from the surface energy, cohesion parameter and particle size of its components?
Pharm Res. 1998 Nov;15(11):1727-36. doi: 10.1023/a:1011960712908.